Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Topic

Treatment (remove)
- HIV drugs (remove)
  - 3TC (lamivudine, Epivir) (remove)
  - Dolutegravir (Tivicay) (4)
- Drug treatment strategies (4)

Filter by Infection

HIV (remove)

Filter by Resource Category

Search results

Current filters: HIV, Treatment, HIV drugs, 3TC (lamivudine, Epivir)

5 search results

Dolutegravir + 3TC for the initial treatment of HIV: From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage
Preliminary results of dolutegravir + 3TC for initial therapy of HIV: From TreatmentUpdate 224
2018, CATIE
Research summary - Webpage
Dolutegravir + 3TC as maintenance therapy—a pilot study: From TreatmentUpdate 224
2018, CATIE
Research summary - Webpage
Dual therapy with dolutegravir + 3TC: From TreatmentUpdate 212
2016, CATIE
Research summary - Webpage
3TC (lamivudine, Epivir): 2014, CATIE
Fact sheet - Webpage

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.